Programme 2018

Wednesday 17th January 2018

Moderator: Hans Eiskjaer

16.00–16.25

Hepatitis C the beginning of the end; is it really all over?

Paolo Grossi
Varese,Italy

16.25–16.50

Primary graft dysfunction biomarkers

Jason Christie
Philadelphia, USA

16.50–17.10

Coffee break

17.10–17.35

Cell free DNA and rejection in Heart Transplantation

Jens Bohmer
Gothenburg, Sweden

17.35–18.00

DCD in Lung Transplantation

Greg Snell
Melbourne, Australia

18.00–19.00

Fascinating Failures and Surprising Successes-Case -
6 Case presentation sections (8 mins. Talk - 2 mins. Questions)

18.00–18.10

Renal failure and VADS

Marie Hogan,
Minnesota, USA

18.10–18.20

We bet you have not seen such a case before

Anja Roden
Minnesota, USA

18.20–18.30

The ground glass dilemma

Erik Verschuuren
Groningen, Netherlands

18.30–18.40

Case series: –extended criteria– for lung transplant recipients.

Peter Riddell
Dublin, Ireland

18.40–18.50

TBC

Jose Gonzalez Costello
Barcelona, Spain

18.50–19.00

Bronchial dehiscence after lung transplant treated with VAC

Andreas Wallinder
Gothenburg, Sweden

Thursday 18th January 2018

Moderator: Göran Dellgren

16.00–16.25

Biopsy differences and DCD vs DBD in Heart Transplantation

Martin Goddard
Cambridge, UK

16.25–16.50

Unloading induced myocardial recovery: mechanistic insights into practical approach to LVAD weaning.

Joseph Stehlik
Salt Lake City, USA

16.50–17.15

The clinical implications of the lung micro biome in Thoracic Transplantation

Sangeta Bhorade
Chicago, USA

17.15–17.40

Donor selection based on Eplet matching in Lung Transplantation

Glen Westall
Melbourne, Australia

17.40–18.00

Coffee break and business meeting during talks

18.00–19.00

WERNER ZUBER MEMORIAL LECTURE

18.00–18.30
Physician climber

Dr Andy Peacock
Glasgow, Scotland

18.30–19.00
General discussion and Business meeting

Friday 19th January 2018

Moderator: Margaret Hannan

16.00–16.25

New data around Community Acquired Respiratory Viruses in Lung Transplantation

Jens Gottlieb
Hannover, Germany

16.25–16.50

Choosing the best system for urgency excalation in Lung Transplantation in Europe

Are Holm
Oslo, Norway

16.50–17.15

Ischemic reperfusion injury in thoracic transplantation – Is it really preventable?

Karl Lemstrom
Helsinki, Finland

17.15–17.50

Coffee break

17.50–19.00

Young investigators (8 mins. Talk - 2 mins. Questions)

17.50–18.00

Sequential lung transplant

Bassem Gadallah
Dublin, Ireland

18.00–18.10

Effects of short and long term cold static preservation followed by normothermic ex vivo lung perfusion in a porcine model

Carolin Olbertz
Essen, Germany

18.10–18.20

Surviving Cepacia Syndrome Post Lung Transplantation

Jana Kleinerova
Dublin, Ireland

18.20–18.30

Cardiac re-transplantation - A reasonable treatment option in selected patients with severe graft failure

Pia Dahlberg
Gothenburg,Sweden

18.30–18.40

Prognostic value of invasive resting and exercise hemodynamics in long-term heart-transplanted patients

Tor Skibsted Clemmensen
Aarhus, Denmark

18.40–18.50

The interleukin-33/ST2 pathway is expressed in the failing human heart and associated with pro-fibrotic

Manon Huibers
Utrecht, Netherlands

18.50–19.00

Optical coherence tomography

Michal Pazdernik
Prague, Czech Republic